Literature DB >> 21288187

Serum apolipoproteins, apoB/apoA-I ratio and objectively measured physical activity in elderly.

Kamran Ahmed1, Peter Rask, Anita Hurtig-Wennlof.   

Abstract

OBJECTIVES: Several studies have suggested that subjectively reported physical activity is associated with favorable apolipoproteins and apoB/apoA-I ratio but this association has not been studied much in elderly, and seldom with objective methods. The specific aim of the current study was to increase our understanding of the association between objectively measured physical activity, and apolipoproteins and apoB/apoA-I ratio in elderly subjects.
DESIGN: In a long-term follow-up of coronary artery bypass graft surgery patients, a total of 89 subjects (55-88 years old) were recruited. Peak oxygen uptake was measured by ergospirometry and physical activity by accelerometry. Subjects were divided into two groups based on their activity levels (i.e. more or less than 30 minutes of moderate activity per day).
RESULTS: Only 26% (23/89) of participants achieved the recommended 30 min/day of moderate intensity activity. Objectively measured physical activity was associated with higher apolipoprotein A-I levels and smaller apoB/apoAI ratio and lower body mass index, whereas no significant association with apolipoprotein B was observed.
CONCLUSION: The significant association of objectively measured physical activity with favorable apolipoprotein A-I levels and a apoB/apoA-I ratio stresses the importance of being physically active.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21288187     DOI: 10.3109/14017431.2011.553966

Source DB:  PubMed          Journal:  Scand Cardiovasc J        ISSN: 1401-7431            Impact factor:   1.589


  1 in total

1.  Sex-specific differences in blood lipids and lipid ratios in type 2 diabetic foot patients.

Authors:  Shuming Yin; Puqing Zhao; Zisheng Ai; Bing Deng; Wei Jia; Huan Wang; Jiaqi Zheng
Journal:  J Diabetes Investig       Date:  2021-07-17       Impact factor: 4.232

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.